<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01030393</url>
  </required_header>
  <id_info>
    <org_study_id>hCG 100</org_study_id>
    <nct_id>NCT01030393</nct_id>
  </id_info>
  <brief_title>Intra-uterine Injection of Human Chorionic Gonadotrophin (hCG) Before Embryo Transfer</brief_title>
  <official_title>Intra-uterine Injection of Human Chorionic Gonadotrophin Before Embryo Transfer in ICSI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Egyptian IVF-ET Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Egyptian IVF-ET Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chorionic gonadotrophins (hCG) play an important role in implantation. The aim of the study&#xD;
      is to evaluate the effect of intrauterine injection of hCG before embryo transfer in IVF/ICSI&#xD;
      on the implantation and pregnancy rates. The rational is that intrauterine hCG injection will&#xD;
      attract regulatory T cells and improve implantation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background :&#xD;
&#xD;
      Human chorionic gonadotrophin ( hCG) was found to secreted immediately after fertilization by&#xD;
      the embryo. It plays an important role in implantation and in attracting regulatory T cells&#xD;
      to the endometrium.&#xD;
&#xD;
      Rational :&#xD;
&#xD;
      Intrauterine injection of hCG before embryo transfer in IVF/ICSI may increase endometrial&#xD;
      regulatory T cells ( Treg ) and improve the implantation and pregnancy rates.&#xD;
&#xD;
      Aim of the work :&#xD;
&#xD;
      To study the effect of intrauterine injection of hCG before embryo transfer on the&#xD;
      implantation and pregnancy rates after IVF/ICSI.&#xD;
&#xD;
      Subjects :&#xD;
&#xD;
      Infertile patients undergoing ICSI.&#xD;
&#xD;
      Inclusion criteria :&#xD;
&#xD;
        -  Female age less than 40 years&#xD;
&#xD;
        -  Male factor infertility&#xD;
&#xD;
        -  Normal female hormonal profile and uterine cavity&#xD;
&#xD;
      Exclusion criteria :&#xD;
&#xD;
        -  Previous ICSI failure&#xD;
&#xD;
        -  Azoospermia&#xD;
&#xD;
        -  Endometriosis&#xD;
&#xD;
      Study group: Intrauterine injection of 100 iu of hCG (group 1)or 200 iu of hCG ( group 2)&#xD;
      will be done during the dummy embryo transfer which is done 10-15 minutes before the actual&#xD;
      embryo transfer.&#xD;
&#xD;
      Control group: The embryo transfer will be done without prior intrauterine injection of hCG&#xD;
&#xD;
      Main outcome measures :&#xD;
&#xD;
      Implantation and pregnancy rates&#xD;
&#xD;
      Secondary outcome measures :&#xD;
&#xD;
      miscarriage and delivery rates&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>implantation and pregnancy rates</measure>
    <time_frame>5 weeks after embryo transfer</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>miscarriage and delivery rates</measure>
    <time_frame>9 months from embryo transfer</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">472</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>intrauterine hCG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental arm : intrauterine injection of 100 iu(group1)or 200 iu (group2) of hCG before embryo transfer.&#xD;
Intrauterine injection of 500 iu hCG before embryo transfer</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>human chorionic gonadotrophin</intervention_name>
    <description>intrauterine injection of 100 iu (group1) or 200 iu (group2) of hCG before embryo transfer in IVF/ICSI And intrauterine injection of 500 iu hCG before embryo transfer .</description>
    <arm_group_label>intrauterine hCG</arm_group_label>
    <other_name>choriomon</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  male factor infertility&#xD;
&#xD;
          -  normal female hormonal profile&#xD;
&#xD;
          -  normal uterine cavity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previous ICSI failure&#xD;
&#xD;
          -  endometriosis&#xD;
&#xD;
          -  azoospermia&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ragaa T Mansour, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Egyptian IVF-ET Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Egyptian IVF- ET center</name>
      <address>
        <city>Cairo</city>
        <zip>11431</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Schumacher A, Brachwitz N, Sohr S, Engeland K, Langwisch S, Dolaptchieva M, Alexander T, Taran A, Malfertheiner SF, Costa SD, Zimmermann G, Nitschke C, Volk HD, Alexander H, Gunzer M, Zenclussen AC. Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J Immunol. 2009 May 1;182(9):5488-97. doi: 10.4049/jimmunol.0803177.</citation>
    <PMID>19380797</PMID>
  </reference>
  <verification_date>August 2012</verification_date>
  <study_first_submitted>December 10, 2009</study_first_submitted>
  <study_first_submitted_qc>December 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2009</study_first_posted>
  <last_update_submitted>August 18, 2012</last_update_submitted>
  <last_update_submitted_qc>August 18, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Egyptian IVF-ET Center</investigator_affiliation>
    <investigator_full_name>Ragaa Mansour</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>hCG</keyword>
  <keyword>pregnancy</keyword>
  <keyword>implantation</keyword>
  <keyword>ICSI</keyword>
  <keyword>IVF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chorionic Gonadotropin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

